Role of Interleukin-35 in sublingual allergy immunotherapy
The Journal of Allergy and Clinical Immunology Jul 30, 2018
Shamji MH, et al. - Authors gauged the mechanisms underlying the induction and maintenance of immunological tolerance induced by IL-35 and iTR35 cells. Findings suggested that potential novel immune-regulators induced by sublingual immunotherapy (SLIT) were IL-35 and iTR35 cells. There was a possibility of the restoration of protective iTR35 cells to underscore the clinical relevance of SLIT. Th2 cell proliferation and cytokine production were suppressed by iTR35 cells.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries